Search Results
Found 50 results for "life sciences" across articles, medicines, trials, companies and the glossary
Industry
Leveraging Real-Time Data Trackers for Clinical Trials and Regulatory Intelligence in the Life Sciences
A comprehensive guide to the architecture, databases, and clinical utility of the real-time data trackers on Priya Life Science, covering trial registries, HPRA authorizations, and supply chain monitors.
Industry
Boston Scientific Prepares to Repatriate 15 Billion Dollars in Dividends from Irish Operation
Boston Scientific has completed a balance sheet reorganisation in Ireland, paving the way to distribute 15 billion dollars in dividends from its Irish subsidiary to global parents.
Industry
22 Irish Companies Recognized in Deloitte EMEA Technology Fast 500 List
Twenty-two high-growth technology companies from the island of Ireland have secured spots on the prestigious Deloitte EMEA Technology Fast 500 list, led by StormHarvester at 24th place.
Industry
Boston Scientific Cybersecurity Incident Disrupts Global Shipping and Order Processing
A cybersecurity incident detected at Boston Scientific on August 25, 2026, has caused a network outage impacting global IT systems and customer order fulfillment, highlighting the sector's vulnerability.
Industry
Unpacking Anthropic's 100-Day Sprint to Reshape Biopharma and Drug Discovery
In a rapid mid-2026 expansion, Anthropic has launched Claude Science, acquired Coefficient Bio, appointed Novartis CEO Vas Narasimhan to its board, and secured a landmark enterprise deal with Bristol Myers Squibb.
Industry
FedEx Launches Dedicated Life Sciences Division to Secure Global Pharmaceutical Logistics
FedEx has consolidated its healthcare logistics capabilities into FedEx Life Sciences, a dedicated business unit led by Nick Gennari that leverages global cold chain centers and real-time monitoring to secure temperature-sensitive pharmaceutical supply chains.
Industry
SK pharmteco Completes Dual Facility Expansion at Swords Campus in Ireland
SK pharmteco has finalized a major manufacturing expansion at its Swords site in Co. Dublin, Ireland. The project adds a multipurpose GMP small-molecule API facility and a kilo-scale GMP HPAPI and ADC payload facility to scale potent therapies from development to commercial supply.
Pharmaceutical
Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma
Irish cannabinoid manufacturer Dunbar Pharma has partnered with IPS Pharma to introduce its EU GMP-certified, plant-derived Dronabinol API, WaterClear THC™, to patients across the United Kingdom.
Industry
TMC Pharma Services Acquires tranScrip to Expand Global Life Science Regulatory and Medical Consulting Capabilities
TMC Pharma Services has acquired contract drug development organization tranScrip, combining clinical trial execution and contract research with deep regulatory affairs, medical, and scientific advisory services.
Industry
William Fry Advises PerkinElmer on Strategic Acquisition of Irish Life Science Automation Leader SimoTech
Project Farma, a division of PerkinElmer, has entered into a definitive agreement to acquire SimoTech, combining commissioning and validation expertise with Cork-based manufacturing automation and GMP IT systems.
Industry
The Housing Bottleneck vs. Biopharma FDI: Are Rent Costs Risking Ireland's Standing as Europe's Pharma Capital?
A critical investigation into how housing scarcity and elevated rental costs in Dublin, Cork, and Limerick are affecting foreign direct investment (FDI) and candidate relocation in Ireland's €138B+ biopharmaceutical sector.
Industry
Daily Rate vs. Salary in Irish Pharma: Is Contracting Still the Fastest Route to Wealth in 2026?
A quantitative financial comparison between permanent corporate employment and daily-rate contracting in Ireland's biopharmaceutical sector. Examining €550 to €850 daily rates, umbrella company setups, tax efficiencies, pension strategies, and job security.
Industry
The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany
An in-depth salary and purchasing power analysis for Ireland's life sciences sector. Comparing gross €100k+ compensation packages against progressive marginal taxes, housing rent, and net disposable income in Dublin and Cork versus Basel, Munich, and Copenhagen.
Industry
Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
An in-depth analysis of Ireland's €93.8 billion pharmaceutical and medical exports to non-EU markets. Examining trade data across the United States, UK, Switzerland, and Asia-Pacific, key manufacturing clusters in Cork, Dublin, and Limerick, and the strategic outlook for 2026.
Industry
Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing
University of Limerick-hosted Rinn Pharma & Biopharma has partnered with NordicPharmaTrain (NPT), a premier European research and training consortium. The milestone collaboration enhances Ireland's global leadership in advanced crystallization, digital manufacturing, sustainable drug formulation, and cross-border researcher mobility.
Industry
Women in Pharma Awards 2026 Recognise Sector’s Outstanding Talent Across Ireland
20 trophies presented at gala Dublin ceremony celebrating leadership, innovation, and clinical trials excellence across Ireland's €100B+ pharmaceutical and life sciences sector.
Industry
The Cost-Governed Enterprise: A Financial Governance Playbook for AI in Irish Life Sciences
MIT research found that 95% of enterprise generative AI pilots show no measurable P&L impact, despite up to €36.8bn of global investment. The failure is not the technology, it is governance: cost is billed and legible, return is diffuse and uninstrumented. A seven-band cost taxonomy, eight load-bearing equations and the make-versus-rent crossover that Irish life sciences boards need to close the gap.
Industry
AI in Pharma H1 2026 Report: Mega-Deals, On-Premise Supercomputer Factories, and Clinical Translation Milestones
A comprehensive half-year update on artificial intelligence in pharmaceutical drug discovery, detailing Isomorphic's $2.1B Series B, Insilico's multi-billion partnerships, NVIDIA's private AI factories, and Phase I/II clinical pipeline progress.
Industry
Using LLMs Safely in Pharma: The Employee Guide to Risk Mitigation, Ethics, and GxP Compliance
An authoritative enterprise guide for pharmaceutical professionals on using Large Language Models (LLMs) safely, mitigating hallucination and data privacy risks, ensuring GxP and EU AI Act compliance, and establishing human-in-the-loop workflows.
Industry
US Pharmaceutical Tariffs Update: Policy Realities, The Stockpile 'Unwind', and Ireland’s Strategic Position
An in-depth analysis of where US pharmaceutical tariff policies stand in mid-2026 under the Trump administration, analyzing recent CSO export data, inventory stockpiling corrections, MFN agreements, and Ireland’s strategic biopharma position.
Industry
US Biopharma Group Pfanstiehl Acquires Nestlé’s Former Askeaton Infant Formula Site in Landmark Mid-West Industrial Transition
In a major boost for Ireland’s Mid-West life sciences hub, US biopharma specialist Pfanstiehl has acquired Nestlé’s former Wyeth Nutritionals plant in Askeaton, Co. Limerick, establishing its first international manufacturing facility.
Industry
ChatGPT Maker OpenAI Selects Dublin Docklands for New European HQ Expansion
OpenAI secures an 88,000 sq ft lease at IPUT's iconic Tropical Fruit Warehouse on Sir John Rogerson's Quay, bringing 250 new high-tech jobs to Dublin as it expands its European headquarters.
Industry
High Expectations, Historic Opportunity: What Ireland’s Rotating EU Council Presidency Can Deliver for European and Irish Pharma
A Priya Life Science White Paper analyzing the pivotal policy dossiers of the 2026 Irish Presidency, the economic stakes for biopharma manufacturing, and key strategic recommendations.
Industry
The Resource Equation: Decoupling Water, Power, and the Shift in Ireland’s Data Centre and Life Sciences Footprint
An in-depth, fact-based analysis of water and power consumption across Ireland’s twin industrial pillars, the infrastructure bottlenecks, and the shifting geography of high-tech construction.
Industry
Quantum 2030: How Ireland’s New Strategic Blueprint Aims to Secure Global Leadership in Quantum Computing
The Irish Government launches "Quantum 2030", a whole-of-government national strategy designed to position Ireland as an internationally competitive hub in quantum technologies, research, and talent by 2030.
Industry
UK Pharma CV Guide 2026: MHRA Standards, Golden Triangle Hubs & Free ATS CV Builder
Complete 2026 guide to writing an ATS-compliant pharmaceutical CV in the UK. Features MHRA & ABPI standards, UK 2-page CV conventions, Golden Triangle recruitment benchmarks, and free ATS CV Studio tools.
Industry
US Pharma Resume Guide 2026: FDA cGMP Standards, ATS Formats & Free Builder
Master the US pharmaceutical resume format in 2026. Covers FDA 21 CFR compliance terms, 1-2 page US resume rules, major US biopharma hubs (Boston, SF Bay, NJ, NC Triangle), and free ATS resume tools.
Industry
ABPI Impact Map Highlights £20.4B Pharma Footprint as UK-Ireland Supply Chain Synergies Deepen
The ABPI launches its updated 2026 Pharmaceutical Impact Map, revealing a £20.4bn economic contribution, 125,702 skilled jobs, and 3,658 NHS collaborations across the UK, while underscoring vital cross-border manufacturing and trade synergies with Ireland.
Industry
GEODIS Expands European Logistics Network with 2,000-Pallet Temperature-Controlled Manchester Pharma Hub
GEODIS opens a state-of-the-art GDP-compliant pharmaceutical hub in Sharston Green, South Manchester, offering 2,000 pallet positions, 15-25°C and 2-8°C climate-controlled storage, and direct air/sea connectivity to Ireland and global markets.
Industry
Registrations Open for TechIreland National AI Challenge 2026: Agentic Workflows, Regional Hubs, and Ecosystem Collaboration
Registrations are now open for the 2026 TechIreland National AI Challenge, delivered in partnership with CeADAR, Enterprise Ireland, and the European Digital Innovation Hubs Network. Learn about the 2026 theme "AI & Agents", key deadlines, regional hubs, and how to register.
Biotechnology
Ireland's Biopharma Manufacturing Hub: A Master Guide to Tax, Talent, CDMO Sourcing, and Regulatory Excellence
An in-depth analysis of Ireland's evolution into Europe's second-largest exporter of medicinal products. Discover how a 12.5% tax structure, NIBRT bioprocessing excellence, HPRA regulatory trust, and a thriving CDMO ecosystem make Ireland the premier location for global drug production.
Industry
Master the Ireland & EU Pharma CV in 2026: HPRA Standards, ATS Templates & Industry Examples
The definitive 2026 guide to writing an ATS-compliant biopharmaceutical CV in Ireland and the EU. Features HPRA & EU Annex 1 standards, GxP bullet point formulas, Irish regional hub insights, and free ATS CV Studio tools.
Industry
The €8.5 Billion Defense: Dutch Innovative Pharma Fights Back Against Cost-Control Policies
The Dutch Association for Innovative Medicines (VIG) releases a detailed report highlighting the sector\'s €8.5 billion gross added value, warning that cost-containment measures threaten patient access, clinical trials, and Europe\'s biopharma sovereignty.
Regulatory Affairs
After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA
A commercial-grade blueprint for the Ireland-India pharma corridor under the EU-India FTA: tariffs, HPRA-CDSCO bridges, 2030 projections, policy asks.
Biotechnology
Bilateral Breakthrough: How the Historic UK-India Free Trade Agreement Transforms Life Sciences and Key Trade Sectors
The historic UK-India Comprehensive Economic and Trade Agreement (CETA) and Double Contributions Convention have officially entered into force, opening duty-free access for pharmaceuticals, dismantling high tariffs on manufacturing inputs, and eliminating dual social security taxes for mobile professionals.
Regulatory Affairs
Transatlantic Tariff Siege: EU Pushes US for €150B Exemption List to Protect MedTech and Spirits
As the Turnberry Deal’s 15% tariff baseline takes hold, Brussels has formally requested carve-outs for €150 billion worth of European goods. The stakes are exceptionally high for Ireland’s €13B medical technology industry, where critical components face severe transatlantic margin pressures.
Regulatory Affairs
GEODIS Expands Pharmaceutical Logistics in Poland: Securing Dual GDP and IATA CEIV Pharma Certifications
GEODIS has renewed its IATA CEIV Pharma accreditation in Warsaw and secured GDP certification for its Stryków Dobra contract logistics facility. This dual compliance milestone bolsters Poland’s status as a critical gateway in Europe’s pharmaceutical supply chain.
Industry
Beyond Google: Why B2B Pharma is Adopting 'Search Everywhere' and Generative Engine Optimization (GEO) in 2026
As professional buyers shift from search engines to AI assistants and LinkedIn for vendor research, B2B pharmaceutical and life science companies are pivoting from traditional keyword rankings to "Search Everywhere" and Generative Engine Optimization (GEO).
Industry
University of Galway to Lead New €64.5m Research Ireland Rinn Medical Devices Centre
The University of Galway has been chosen to lead the new €64.5 million Research Ireland Rinn Medical Devices Centre as part of a landmark €460 million government investment in seven new national Rinn research centres.
Industry
The Distortion of Irish GDP: How 'Phantom Exports' Are Reshaping the Biopharma Landscape
Ireland's contract manufacturing exports-colloquially known as "phantom exports"-are surging once again, raising fresh questions about the decoupling of headline economic figures from the domestic life sciences economy.
Pharmaceutical
The Anatomy of a Biologics Warning Letter: Deconstructing Genzyme Waterford’s FDA Audit
The FDA CBER warning letter issued to Genzyme Ireland’s Waterford site in June 2026 is a watershed moment for Irish biopharma. From 11x repeated filter tests to discarded checklists and unexplained deviation cancellations, we analyze the specific CGMP violations and detail what this compliance failure means for quality management across the sector.
Pharmaceutical
The Complete LinkedIn Brand-Building Playbook for Pharma and Life Sciences
LinkedIn is the most powerful platform for pharmaceutical and life sciences professionals to build authority and reach target customers. This complete guide covers company page setup, what to post, best times to publish, how to grow connections, and how to turn LinkedIn into a consistent pipeline.
Pharmaceutical
The Newsletter Advantage: How Pharma Companies Use Email to Reach the Right People Every Time
Newsletters are the most cost-effective marketing tool for pharmaceutical companies. Unlike social media, a newsletter lands directly in the inbox of every person who chose to hear from you. This step-by-step guide explains how to set one up, what to put in it, and how to reach target customers efficiently.
Biotechnology
The Dublin-Backed Roll-Up Reshaping UK Pharma Packaging: Inside Woodberry's Double Acquisition
In a deal announced on July 7, 2026, Woodberry Packaging - the Dublin-backed packaging group led by veteran entrepreneur Patrick Doran - has acquired Medica Packaging, the UK's largest independent pharmaceutical carton converter, and F.G. Curtis, a respected name in cosmetics and personal care packaging. The combined group now employs 650 people across the UK and Ireland with revenues exceeding €120 million, marking a significant consolidation moment in the specialist packaging sector.
Regulatory Affairs
Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots
The UK government and the pharmaceutical industry have launched a series of pilot schemes designed to accelerate NHS patient access to innovative medicines - a direct consequence of the US-UK pharmaceutical trade arrangement that has already rewritten the terms of how Britain prices, approves, and funds new drugs. But with a BMJ analysis warning of £45 billion in diverted NHS resources and up to 229,000 excess deaths by 2036, the pilots are arriving in the middle of one of the most contested healthcare policy disputes in a generation.
Regulatory Affairs
Data Integrity and Quality Oversight: Analyzing the FDA Warning Letter for Sanofi's Waterford Site
Following a January 2026 inspection, the FDA has issued a formal warning letter to Genzyme Ireland Limited in Waterford, citing data integrity concerns, uncontrolled checklists, and quality unit oversight gaps in the manufacturing of Thymoglobulin and Altuviiio.
Regulatory Affairs
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals
In a landmark world-first, Irish-founded Chanelle McCoy Health has received official regulatory approvals from the Saudi Food and Drug Authority and confirmation of safety under EU Novel Food guidelines for its Pureis® Ultra Pure CBD range.
Industry
Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs
An in-depth analysis of two newly opened funding opportunities-Women TechEU and Innovate UK's Next Wave Createch-designed to support early-stage deep tech and creative technology innovators across Europe and the UK.
Regulatory Affairs
FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings
The FDA has issued a formal warning letter to Sanofi's Waterford facility, Genzyme Ireland Limited, citing data integrity breaches, discarded quality records, and botched deviation investigations in the production of haemophilia drug Altuviiio and transplant therapy Thymoglobulin.
Industry
The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs
From Enterprise Ireland feasibility grants and Local Enterprise Office funding to seed venture capital and angel networks, this is the ultimate blueprint for starting and scaling a business in Ireland.